Skip to main content
Clinical Trials/NCT04316156
NCT04316156
Completed
N/A

Hospital-home Linkage Short-term Rehabilitation Therapy Using Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled Trial, Assessor Blinding, Multi-center Study

Samsung Medical Center2 sites in 1 country100 target enrollmentApril 1, 2020
ConditionsBreast Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Samsung Medical Center
Enrollment
100
Locations
2
Primary Endpoint
Range of motion in affected shoulder
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study aims to examine the effect of hospital-home linkage short-term rehabilitation therapy using real-time interactive digital healthcare system (Uincare Homeplus) in post-operative patients with breast cancer. This is prospective study. 100 breast cancer patients who underwent axillary lymph node diessection or breast reconstruction following mastectomy will be examined, and those with limited range of motion (ROM) of affected shoulder will be enrolled in the study. Shoulder ROM, Quick-DASH, pain evaluation with NRS, quality of life evaluation with FACT-B and EQ-5D will be evaluated on enrollment, 4-week, 8-week, and 12-weeks after enrollment.

Detailed Description

The limited range of motion (ROM) of the shoulder occur often after receiving breast cancer surgery, which may be due to post-operative pain, stiffness of shoulder girdle muscle, and etc. Due to this limited ROM, the patients may have difficulty with activities of daily life and quality of life may be reduced. Uincare Homeplus is software manufactured in Korea, which uses infrared, kinect camera and motion capture technology to track 3D motion of the patients' articulation. Using this technology, the patients can receive feedback of their motion immediately. The objective of the study is to examine the effect of hospital-home linkage short-term rehabilitation therapy using real-time interactive digital healthcare system (Uincare Homeplus) in post-operative patients with breast cancer.

Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
November 17, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

JiHye Hwang

Professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients who underwent breast cancer surgery (axillary lymph node dissection or breast reconstruction following mastectomy)
  • Limited active/passive range of motion of the affected shoulder (Flexion \<160' or Abduction \<160')
  • post-operative day not exceeding 8 week
  • Patients who agreed informed consent

Exclusion Criteria

  • Bilateral breast cancer surgery
  • Patients with shoulder pain and limited ROM before breast cancer surgery
  • Those unable to perform exercise due to general deconditioning
  • Those with communication difficulty

Outcomes

Primary Outcomes

Range of motion in affected shoulder

Time Frame: Enrollment, 4 week, 8 week, 12 week

Evaluation of change in range of motion of the affected shoulder from baseline to 12 weeks

Secondary Outcomes

  • Quality of life in the patient with breast cancer (1)(Enrollment, 4 week, 8 week, 12 week)
  • Quality of life in the patient with breast cancer (2)(Enrollment, 4 week, 8 week, 12 week)
  • Functional outcome (Quick Disability of Arm, Shoulder, Hand)(Enrollment, 4 week, 8 week, 12 week)
  • Numerical rating scale of affected shoulder(Enrollment, 4 week, 8 week, 12 week)

Study Sites (2)

Loading locations...

Similar Trials